Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Ribbon symbolism Stories

2014-03-04 23:03:52

The HERS Breast Cancer Foundation is proud to announce the expansion of its services to breast cancer survivors with the opening of a new store February 19, at the Stanford Cancer Center. Fremont, California (PRWEB) March 04, 2014 The HERS Breast Cancer Foundation is proud to announce the expansion of its services to breast cancer survivors with the opening of a new store February 19, at the Stanford Cancer Center. The Stanford Cancer Center empowers collaboration, fosters...

2014-03-04 14:19:32

For women with breast cancer undergoing radiation therapy, yoga offers unique benefits beyond fighting fatigue, according to research from The University of Texas MD Anderson Cancer Center. The preliminary findings were first reported in 2011 by Lorenzo Cohen, Ph.D., professor and director of the Integrative Medicine Program at MD Anderson, and are now published in the Journal of Clinical Oncology. This research is part of an ongoing effort to scientifically validate mind-body...

2014-03-04 12:25:57

Unequal access to diagnosis and treatment results in deaths of 1,710 black women annually NEW YORK, March 4, 2014 /PRNewswire-USNewswire/ -- A national study published today found a black: white disparity in breast cancer mortality in 39 of the most populous U.S. cities, with 35 of those cities experiencing a widening disparity over a 20-year period from 1990 to 2009. The 2014 Racial Disparity in Breast Cancer Mortality Study is the largest study of its kind and the first to examine racial...

2014-03-03 15:25:51

Researchers from UCLA's Jonsson Comprehensive Cancer Center have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength. The research findings by UCLA's Jeffrey Zink, a professor of chemistry and biochemistry, and Fuyu Tamanoi, a professor of microbiology, immunology and molecular genetics, and their colleagues were...

2014-03-03 08:31:29

New products including lower-dose tomosynthesis and tomosynthesis-guided biopsy to be showcased for the radiology community BEDFORD, Mass., March 3, 2014 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, will showcase its extensive portfolio of innovative products for breast cancer...

Better Cancer Treatments May Follow Research In Outer Space
2014-02-28 10:25:13

Rebekah Eliason for redOrbit.com – Your Universe Online Although a necessary evil for a vast amount of people, systemic cancer treatment is an invasive procedure with devastating side effects. People undergoing cancer treatment often experience nausea, immune suppression, hair loss and organ failure. All of this is endured with the hope of exterminating the cancerous tissues in the body. If a treatment were developed to specifically target the cancerous tissue instead of treating the...

2014-02-27 16:28:16

ThermoDox Demonstrates Impressive Response Rate in Refractory Patients LAWRENCEVILLE, N.J., Feb. 27, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in Recurrent Chest Wall Breast Cancer (RCWBC). The trial will enroll 20 patients at 5 clinical sites in the United States and is evaluating ThermoDox in combination with mild hyperthermia. Based on data available to date, a...

2014-02-27 12:27:11

WORCESTER, Mass. and TORONTO, Feb. 27, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of studies examining potential biomarkers associated with overall survival in prostate cancer patients treated with its immunotherapeutic agent AE37. The retrospective study examined data from 29 patients immunized as part of a Phase I study. The immunotherapeutic agent AE37 is being developed by Antigen Express, Inc....

2014-02-27 08:30:00

Patient Recruitment Now Underway at Treatment Centers Across the United States WOODCLIFF LAKE, N.J., Feb. 27, 2014 /PRNewswire/ -- Eisai Inc. today announced the start of a large, randomized Phase 3 trial to compare the efficacy, safety and tolerability of eribulin mesylate to standard weekly paclitaxel as a first- or second- line treatment for HER2-negative locally recurrent or metastatic breast cancer (MBC). Recruitment is currently active for this multicenter study, conducted in...

2014-02-26 23:34:39

Cancer-Code Corporation announces the issuance of U.S. Patent No. 8,656,930: “Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy." Albuquerque, NM (PRWEB) February 26, 2014 Cancer-Code Corporation (C3) announces the issuance of U.S. Patent No. 8,656,930 on February 25, 2014. The ‘930 patent, entitled “Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy,” covers a breakthrough technological approach to...